Clinical Trial Update: GM-CSF for Reversal of immunopAralysis in pediatriC sEpsis-induced MODS Study [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating GM-CSF for reversal of immunoparalysis in pediatric sepsis-induced MODS; study status is ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis-induced Multiple Organ Dysfunction Syndrome

Drugs mentioned

• GM-CSF (granulocyte-macrophage colony-stimulating factor)

Snippet

Sponsor: Nationwide Children's Hospital | Conditions: Pediatric Sepsis-induced MODS | Phase 4 | Status: ACTIVE_NOT_RECRUITING